Piribo: Successfully investing in Central Eastern Europe pharmaceutical markets.

The CEE accession to the European Union in May 2004 has removed many barriers to a potential pharmaceutical market, accounting for 309 million people, with an aggregate GDP of US$1.5 trillion in 2005. Knowing that the CEE had to comply with the EU pharmaceutical legislation, significant improvement in the quality standards and rise in market values are to be expected. This market should be of strong interest to any pharmaceutical company willing to expand.

The attractiveness of these markets is clearly put into perspective by this up-to-date report, through its coverage of 11 key markets (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, and Ukraine).

This report features:

An in depth analysis of each market inclusive of external factors (regulatory, political economic and corporate developments)
A unique 5-year market projection
An accurate synthesis of drug demand current trends
A quarterly updated review.

“The Outlook for Pharmaceuticals in Central & Eastern Europe” is priced at £1,495.00 and is available in PDF format. For more information, go to: http://www.piribo.com/search/results.html?k=ESP801

About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,500 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.